Komori
Avix (7836) · RiskReframed

Business Performance and Supply Risks From the Spread of COVID-19

First written in FY2020. 6 of 14 entries say "Mitigated", first in FY2021-Q2. Latest entry: FY2026.

14entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMitigatedFY2023-Q2 – FY2024-Q1RestatedFY2024-Q22020: 320202021: 420212022: 420222023: 220232024: 020242025: 020252026: 12026
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1346 companies write about · 1357 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1371 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「If unforeseen circumstances occur in Japan or overseas, such as natural disasters including typhoons, earthquakes and tsunamis; diseases or social unrest caused by the emergence or spread of a pandemic; an economic crisis caused by disruptions in financial or capital markets; or political turmoil caused by riots or terrorism, they may affect the performance of the Group.」

    The wording has been generalized from an explanation specifically mentioning COVID-19 to the broader risk of unforeseen circumstances, including diseases and pandemics.
  2. FY2024-Q2RestatedAnnual report

    「During the six-month period of the current fiscal year, COVID-19 was reclassified as a Category V infectious disease in Japan, economic activity moved toward normalization, and signs of a gradual recovery were observed.」

    The reclassification of COVID-19 as a Category V infectious disease, the normalization of economic activity and signs of a gradual recovery continue to be described.
  3. FY2024-Q1MitigatedAnnual report

    「During the three-month period of the current fiscal year, COVID-19 was reclassified as a Category V infectious disease in Japan, economic activity moved toward normalization, and signs of a gradual recovery were observed.」

    The reclassification of COVID-19 as a Category V infectious disease and the normalization of economic activity are described, indicating an easing of the previous risk of economic stagnation caused by the infection. However, uncertainty over the outlook remains.
  4. FY2023-Q2MitigatedAnnual report

    「During the six-month period of the current fiscal year, Japan's economy entered a recovery trend, with personal consumption and capital investment showing signs of recovery due to the easing of restrictions on activities associated with COVID-19.」

    The easing of restrictions on activities associated with COVID-19 led to a recovery in personal consumption and capital investment, and the economy was described as entering a recovery trend.
  5. FY2023-Q1WorsenedAnnual report

    「However, the outlook remained uncertain due to surging resource prices resulting from the prolonged situation in Ukraine, a sharp depreciation of the yen due to the widening interest-rate differential between Japan and the United States, and the recent resurgence of COVID-19 infections.」

    As the impact of the infection has continued for an extended period, the assessment indicates that infections are currently spreading again and that the uncertain outlook has continued.
  6. FY2022MitigatedAnnual report

    「The impact of the spread of COVID-19 is currently minor. However, depending on future developments, it may affect the performance of the Group, and we believe it is necessary to continue monitoring the situation.」

    The current impact of COVID-19 is assessed as minor, representing an easing from the previously described actual impact on supplies and performance. However, the possibility of a future impact remains.
  7. FY2022-Q3WorsenedAnnual report

    「During the nine-month period of the current fiscal year, the impact of COVID-19 remained prolonged. Although vaccinations progressed and the number of new infections temporarily declined, the outlook remained uncertain due to the spread of infections involving new variants.」

    Although vaccinations and a temporary decline in the number of new infections occurred, the uncertain outlook has continued due to the spread of infections involving new variants.
  8. FY2022-Q2RestatedAnnual report

    「During the six-month period of the current fiscal year, Japan's economy remained in a difficult situation due to the prolonged impact of COVID-19, but there were also positive developments, including a higher vaccination rate and a decline in the number of new infections.」

    Although the difficult economic conditions caused by the infection have continued, mitigating factors, including a higher vaccination rate and a decline in the number of new infections, have also been noted, while the previous risk assessment remains in place.
  9. FY2022-Q1MitigatedAnnual report

    「During the three-month period of the current fiscal year, Japan's economy remained in an uncertain situation due to the spread of COVID-19, but there were also positive developments, including signs of recovery in some areas. In addition, economic recovery is expected as vaccinations progress.」

    Although the uncertain situation caused by the infection has continued, expectations for economic recovery based on a partial recovery and vaccinations are noted, indicating an easing of the risk assessment.
  10. FY2021MitigatedAnnual report

    「The impact of the spread of COVID-19 is currently minor. However, depending on future developments, it may affect the performance of the Group, and we believe it is necessary to continue monitoring the situation.」

    The impact of COVID-19 is assessed as minor at present, but the possibility remains that future developments could affect performance.
  11. FY2021-Q3WorsenedAnnual report

    「During the nine-month period of the current fiscal year, Japan's economy stagnated due to the spread of COVID-19. Although there were subsequently signs of improvement as social and economic activity resumed, infections began to spread again, and uncertainty over the outlook has increased.」

    The assessment indicates that, after signs of improvement resulting from the resumption of economic activity, infections began to spread again and uncertainty over the outlook increased.
  12. FY2021-Q2MitigatedAnnual report

    「Regarding the economic outlook, although economic conditions have shown signs of recovery recently as economic activity resumes, the timing of the containment of COVID-19 remains unforeseeable, and the situation continues to warrant caution.」

    Although economic conditions were said to be showing signs of recovery as economic activity resumed, the timing of the containment of the infection remains unforeseeable, and the risk is not described as having been eliminated.
  13. FY2021-Q1WorsenedAnnual report

    「During the first-quarter consolidated cumulative period, Japan’s economy was in an extremely severe situation as social and economic activity rapidly stagnated, including restrictions on economic activity due to the spread of COVID-19. Although the state of emergency had been lifted, concerns remained about a second wave of COVID-19, and the outlook continued to be unpredictable.」

    The risk is described as continuing and expanding, amid a rapid and ongoing slowdown in economic activity caused by COVID-19 and concerns over the arrival of a second wave.
  14. FY2020MaterialisedAnnual report

    「During the current consolidated fiscal year, the factories of the Company’s Chinese partner companies operated at reduced capacity, affecting business performance. Going forward, however, the partner companies’ operations have recovered, and the impact is expected to be minor. Nevertheless, depending on the future spread of the infection, it could affect the Company’s business performance.」

    While the spread of COVID-19 actually resulted in reduced operations at the factories of Chinese partner companies and a decline in sales, as of the filing date, the Company indicated that operations at those partner companies had recovered and that the impact was expected to be minor.
Moved together

"Going-Concern Risk Due to Operating Losses and Negative Operating Cash Flow" moved the same way as this thread, in the same document, in 7 of its 14 moves.

765544★123456
  1. ★This thread
  2. 1Going-Concern Risk Due to Operating Losses and Negative Operating Cash Flow7×
  3. 2Expansion Beyond the Pachinko Hall Market6×
  4. 3Product development centered on communications networks and collaboration with external companies5×
  5. 4Expansion of the large-format display market driven by lower product prices and Olympic demand5×
  6. 5Synergies among the equipment, operations and information equipment businesses4×
  7. 6Developing the Value creating business into a future core business4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Avix's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.